143 related articles for article (PubMed ID: 10616523)
21. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
[TBL] [Abstract][Full Text] [Related]
22. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.
Bertrums EJ; Buijs A; van Grotel M; Dors N; de Rooij JD; de Haas V; Hopman S; Jongmans MC; Zwaan CM; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667142
[TBL] [Abstract][Full Text] [Related]
23. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
[TBL] [Abstract][Full Text] [Related]
24. Origins of leukaemia in children with Down syndrome.
Hitzler JK; Zipursky A
Nat Rev Cancer; 2005 Jan; 5(1):11-20. PubMed ID: 15630411
[TBL] [Abstract][Full Text] [Related]
25. The use of the anti-factor VIII method on trephine biopsies of the bone marrow for the identification of immature and atypical megakaryocytes in myeloproliferative diseases and allied disorders. A morphometric study.
Thiele J; Krech R; Wienhold S; Simon KG; Zankovich R; Fischer R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 54(2):89-97. PubMed ID: 2892311
[TBL] [Abstract][Full Text] [Related]
26. Acute Megakaryocytic Leukemia arising from Megakaryocyte/Erythroid Progenitor (MEP)-like cell.
Chan SSW; Lee SY
Int J Lab Hematol; 2022 Oct; 44(5):808-811. PubMed ID: 35261171
[No Abstract] [Full Text] [Related]
27. Establishment of a new human megakaryoblastic cell line, CMY, with chromosome 17p abnormalities.
Miura N; Sato T; Fuse A; Okimoto Y; Kinugawa N; Horie H; Ota S; Kakuda H; Yokoe H; Miya T; Suzuki N; Niimi H
Int J Mol Med; 1998 Mar; 1(3):559-63. PubMed ID: 9852262
[TBL] [Abstract][Full Text] [Related]
28. Activating mutations in human acute megakaryoblastic leukemia.
Malinge S; Ragu C; Della-Valle V; Pisani D; Constantinescu SN; Perez C; Villeval JL; Reinhardt D; Landman-Parker J; Michaux L; Dastugue N; Baruchel A; Vainchenker W; Bourquin JP; Penard-Lacronique V; Bernard OA
Blood; 2008 Nov; 112(10):4220-6. PubMed ID: 18755984
[TBL] [Abstract][Full Text] [Related]
29. Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic Cooperations.
Lopez CK; Malinge S; Gaudry M; Bernard OA; Mercher T
Trends Cancer; 2017 Sep; 3(9):631-642. PubMed ID: 28867167
[TBL] [Abstract][Full Text] [Related]
30. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.
Hama A; Yagasaki H; Takahashi Y; Nishio N; Muramatsu H; Yoshida N; Tanaka M; Hidaka H; Watanabe N; Yoshimi A; Matsumoto K; Kudo K; Kato K; Horibe K; Kojima S
Br J Haematol; 2008 Mar; 140(5):552-61. PubMed ID: 18275433
[TBL] [Abstract][Full Text] [Related]
31. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
Crispino JD
Pediatr Blood Cancer; 2005 Jan; 44(1):40-4. PubMed ID: 15390312
[TBL] [Abstract][Full Text] [Related]
32. Human megakaryocytic progenitor cells.
Kanz L; Löhr GW; Fauser AA
Klin Wochenschr; 1987 Apr; 65(7):297-307. PubMed ID: 2438450
[TBL] [Abstract][Full Text] [Related]
33. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
[TBL] [Abstract][Full Text] [Related]
34. A t(1;22)(p13;q13) in four children with acute megakaryoblastic leukemia (M7), two with Down syndrome.
Trejo RM; Aguilera RP; Nieto S; Kofman S
Cancer Genet Cytogenet; 2000 Jul; 120(2):160-2. PubMed ID: 10942809
[TBL] [Abstract][Full Text] [Related]
35. Retroviral mediated gene transfer in megakaryocytic cell lines.
Kiffmeyer WR; Stambrook PJ; Lieberman MA
In Vitro Cell Dev Biol Anim; 1994 Nov; 30A(11):803-9. PubMed ID: 7881634
[TBL] [Abstract][Full Text] [Related]
36. Histopathological analysis of cases of megakaryocytic leukemia.
Watanabe Y; Enomoto Y; Yamada T; Harigaya K
Keio J Med; 1987 Jan; 36(1):71-3. PubMed ID: 3475495
[No Abstract] [Full Text] [Related]
37. JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults.
Kiyoi H; Yamaji S; Kojima S; Naoe T
Leukemia; 2007 Mar; 21(3):574-6. PubMed ID: 17252020
[No Abstract] [Full Text] [Related]
38. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
[TBL] [Abstract][Full Text] [Related]
39. The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome.
Harigae H; Xu G; Sugawara T; Ishikawa I; Toki T; Ito E
Blood; 2004 Apr; 103(8):3242-3. PubMed ID: 15070711
[No Abstract] [Full Text] [Related]
40. Transient abnormal myelopoiesis followed by acute megakaryoblastic leukemia with extramedullary tumors. An autopsied case of Down's syndrome.
Nito T; Terashima K; Matsuda M; Imai Y; Yokoyama S; Hayashi T
Acta Pathol Jpn; 1983 Sep; 33(5):1027-39. PubMed ID: 6228108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
